TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22353022

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg weekly for 96 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 19965682

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Major surgery
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Minor surgery
Number of subjects: 614
Study: 17223655

Group type: EXPERIMENTAL
Intervention: Intra-articular (90)Y distribution mainly diffuse
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intra-articular (90)Y distribution mainly focal
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: (90)Y leakage to liver
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: (90)Y leakage to spleen
Number of subjects: 69

Group type: COMPARATOR
Intervention: Diffuse intra-articular (90)Y distribution
Number of subjects: 69
Study: 16282540

Group type: EXPERIMENTAL
Intervention: Basic rehabilitation program with additional arm, leg, or air splint therapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Time itself
Number of subjects: 101
Study: 11995883

Group type: EXPERIMENTAL
Intervention: Classical posterior approach (Group 1)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Modified posterior approach (Group 2)
Number of subjects: 183
Study: 9481631

Group type: EXPERIMENTAL
Intervention: Zinc-fortified bread providing 2 mg/kg/day elemental zinc acetate for 90 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (same quality bread with no zinc fortification)
Number of subjects: 24
Study: 7874898

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg four times daily added to standard enteral nutrition feeding protocol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard enteral nutrition feeding protocol without cisapride
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 21
Study: 2404046

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg once a day)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg three times a day)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole (325 mg and 75 mg together three times a day)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone (267 mg three times a day)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Placebo (nonaspirin group)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Aspirin group
Number of subjects: 772
Study: 369471

Group type: EXPERIMENTAL
Intervention: 1 mg of DTgammaE zinc phosphate daily intramuscularly for about seven days (study 1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 1 mg of nonlasting DTgammaE in saline daily intramuscularly for eight days (study 2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Neuroleptic therapy maintained in six patients and drug-free in two patients (study 2)
Number of subjects: 14
Study: 31315417

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 248
Study: 27853913

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS) with double embryo transfer (DET)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS) with single embryo transfer (SET)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Non-PGS embryo transfers
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 398
Study: 25886384

Group type: EXPERIMENTAL
Intervention: Combined nutraceutical containing berberine, chlorogenic acid and tocotrienols
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23644921

Group type: EXPERIMENTAL
Intervention: Immediate postpartum curettage
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group (no curettage)
Number of subjects: 420
Study: 21639638

Group type: EXPERIMENTAL
Intervention: Basic computer‐tailored print intervention
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Environmentally computer‐tailored print intervention
Number of subjects: 1971

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 1971
Study: 19894301

Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) combined with standard rehabilitation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 55
Study: 16996599

Group type: EXPERIMENTAL
Intervention: Rebound tonometer (RBT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dynamic contour tonometer (DCT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rebound tonometer (RBT) and Dynamic contour tonometer (DCT)
Number of subjects: 90
Study: 15207200

Group type: EXPERIMENTAL
Intervention: Pharmaceutical intervention in a monitoring programme for type-2 diabetics
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study: 11132738

Group type: EXPERIMENTAL
Intervention: Tilt group (supine with a 30 degree leftward tilt)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Lateral group (left lateral decubitus position)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Lateral group
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Tilt group
Number of subjects: 293
Study: 9102059

Group type: EXPERIMENTAL
Intervention: 400 IU intranasal calcitonin daily
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 20 intramuscular injections of 50 mg nandrolone decanoate plus placebo nasal spray
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 20 injections of 50 mg nandrolone decanoate plus 400 IU intranasal calcitonin daily
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intranasal calcitonin
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate and intranasal calcitonin
Number of subjects: 123
Study: 8110036

Group type: EXPERIMENTAL
Intervention: Volumatic spacer device
Number of subjects: 18

Group type: COMPARATOR
Intervention: Corniced extension tube
Number of subjects: 18
Study: 2871785

Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31928372

Group type: EXPERIMENTAL
Intervention: Pattern matching method for identifying advanced cancer patients
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: ICD-10 algorithm for identifying advanced cancer patients
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Refined ICD-10 algorithm excluding hematological malignancies
Number of subjects: 586
Study: 29520735

Group type: EXPERIMENTAL
Intervention: ART (IVF and ICSI)
Number of subjects: 460

Group type: COMPARATOR
Intervention: non-ART (IUI and OI)
Number of subjects: 460
Study: 26608279

Group type: EXPERIMENTAL
Intervention: SET with values affirmation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SET
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 24420765

Group type: EXPERIMENTAL
Intervention: Working memory (WM) training program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 62
Study: 22289649

Group type: EXPERIMENTAL
Intervention: Menaquinone-7 (MK-7) supplementation at doses around RDA (10, 20, 45, 90, 180, or 360 μg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 42
Study: 20833391

Group type: EXPERIMENTAL
Intervention: Self-adhesive mesh (Parietene Progrip(®))
Number of subjects: 90

Group type: COMPARATOR
Intervention: Polypropylene mesh fixed with a monofilament suture
Number of subjects: 90
Study: 19134299

Group type: EXPERIMENTAL
Intervention: Aortic root dimension (ARD) measurement in ACI patients
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group without cerebral infarction or organic heart disease
Number of subjects: 110

Group type: COMPARATOR
Intervention: Comparison of ARD between ACI patients and control subjects
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis of ARD as a risk factor for ACI
Number of subjects: 110
Study: 15926290

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 33
Study: 12663728

Group type: EXPERIMENTAL
Intervention: Tobacco Intervention (TI) group received intensive late effects risk counseling, educational video, goal setting, written physician feedback, smoking literature, and follow-up telephone counseling.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard Care Control (SCC) group received standard advice about the risks of tobacco use.
Number of subjects: 103
Study: 11097130

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy
Number of subjects: 1430

Group type: COMPARATOR
Intervention: No reperfusion therapy
Number of subjects: 1430
Study: 8644836

Group type: EXPERIMENTAL
Intervention: Pet therapy intervention for 1 hr a day for 5 consecutive days
Number of subjects: 58

Group type: COMPARATOR
Intervention: Exercise control for 1 hr a day for 5 consecutive days
Number of subjects: 58
Study: 1996747

Group type: EXPERIMENTAL
Intervention: Propofol/Ketamine combination
Number of subjects: 18

Group type: COMPARATOR
Intervention: Propofol/Fentanyl combination
Number of subjects: 18
Study: 6825409

Group type: EXPERIMENTAL
Intervention: High animal protein diet (HPD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low animal protein diet (LPD)
Number of subjects: 8
Study: 31791285

Group type: EXPERIMENTAL
Intervention: Mobile enhanced Family Integrated Care (mFICare)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Family Centered Care (FCC)
Number of subjects: 0
Study: 27920258

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: High-Intensity Continuous Training (HICT)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Non-Exercise Control (NON-EX)
Number of subjects: 280
Study: 26674907

Group type: EXPERIMENTAL
Intervention: Eggshell-derived hydroxyapatite (EHA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Synthetic hydroxyapatite (SHA)
Number of subjects: 20
Study: 24279638

Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatment (12 sessions for 6 weeks)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard-of-care pharmacologic treatment
Number of subjects: 153
Study: 23010556

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (n=586)
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Control group (n=594)
Number of subjects: 1180
Study: 18795255

Group type: EXPERIMENTAL
Intervention: AVAPS therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: NIV-PS therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lateral decubitus position
Number of subjects: 28
Study: 17113635

Group type: EXPERIMENTAL
Intervention: Clearfil SE bond with 10 s air drying
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clearfil Tri-S bond with 10 s air drying
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clearfil SE bond with 2 s air drying
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Clearfil Tri-S bond with 2 s air drying
Number of subjects: 10
Study: 15088288

Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg daily by injection
Number of subjects: 1399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1399
Study: 11699675

Group type: EXPERIMENTAL
Intervention: Animal-based model
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Biology-based model
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Psychological capacities attribution
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Finalist model
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Complexity-based teleology
Number of subjects: 104
Study: 9554521

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) modulated by 6S‐leucovorin (6S‐LV)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Epirubicin, etoposide, cisplatin, and lonidamine (EEP‐L)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both treatments (5‐FU/6S‐LV and EEP‐L)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 5‐FU/6S‐LV
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: EEP‐L
Number of subjects: 72
Study: 8155091

Group type: EXPERIMENTAL
Intervention: AHA type diet 32/10:8:8
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: monoene‐enriched diet 34/11:11:5
Number of subjects: 160

Group type: COMPARATOR
Intervention: reduced‐fat diet 30/12:8:3
Number of subjects: 160

Group type: COMPARATOR
Intervention: control diet 35/14:10:4
Number of subjects: 160
Study: 3046542

Group type: EXPERIMENTAL
Intervention: Transdermal clonidine hydrochloride (Catapres‐TTS No. 2) treatment for one week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study: 28700515

Group type: EXPERIMENTAL
Intervention: TR1: 3 × 10 [0 seconds]
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CL2: 3 × 10 [15 seconds]
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CL3: 3 × 10 [30 seconds]
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: TR2: 6 × 5 [0 seconds]
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CL1: 3 × 10 [10 seconds]
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CL4: 1 × 30 [15 seconds]
Number of subjects: 11
Study: 30641885

Group type: EXPERIMENTAL
Intervention: No-anesthesia (RIPC)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sevoflurane (RIPC)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Propofol (RIPC)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: No carvedilol (RIPC)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Carvedilol (RIPC)
Number of subjects: 61
Study: 28789681

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Baduanjin
Number of subjects: 189

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 189
Study: 25403343

Group type: EXPERIMENTAL
Intervention: Oral topiramate (TPM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravenous topiramate (TPM)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 100 mg dose
Number of subjects: 100
Study: 24041732

Group type: EXPERIMENTAL
Intervention: Group Based Antenatal Care (GBAC)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 700
Study: 21565325

Group type: EXPERIMENTAL
Intervention: Structured exercise training plus usual care
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2331
Study: 19096005

Group type: EXPERIMENTAL
Intervention: A allele of promoter SNP rs2241712
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: C allele of SNP rs1800469
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: C allele of exonic SNP rs1800471
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: T allele of coding SNP rs1982073
Number of subjects: 881
Study: 17008336

Group type: EXPERIMENTAL
Intervention: Patient education-exercise group (n=97)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Relaxation group (n=86)
Number of subjects: 183
Study: 15249451

Group type: EXPERIMENTAL
Intervention: Low‐radiation‐dose spiral CT (LDCT) scan
Number of subjects: 3318

Group type: COMPARATOR
Intervention: Chest radiograph (CXR)
Number of subjects: 3318
Study: 12034159

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels measured in patients with heart failure
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: NYHA functional class on discharge
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CRP levels >0.9 mg/dl
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CRP levels, NYHA class, plasmatic K on discharge, left ventricle ejection fraction
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Follow-up for 18 months
Number of subjects: 76
Study: 9807674

Group type: EXPERIMENTAL
Intervention: Beta-thalassaemia trait screening
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Microcytic subjects screening
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Discrimination functions for beta-thalassaemia trait
Number of subjects: 1650
Study: 7652502

Group type: EXPERIMENTAL
Intervention: Meropenem monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefotaxime-based regimens
Number of subjects: 0
Study: 2524166

Group type: EXPERIMENTAL
Intervention: 10 ng.kg‐1.min‐1 ANF infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 25 ng.kg‐1.min‐1 ANF infusion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 22
Study: 1119691

Group type: EXPERIMENTAL
Intervention: Immediate bilateral oophoroadrenalectomy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional therapy without endocrine ablation
Number of subjects: 122
Study: 31629404

Group type: EXPERIMENTAL
Intervention: Moderate NMB with sugammadex reversal
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Moderate NMB with neostigmine reversal
Number of subjects: 55

Group type: COMPARATOR
Intervention: Shallow NMB with sugammadex reversal
Number of subjects: 55

Group type: COMPARATOR
Intervention: Shallow NMB with no reversal
Number of subjects: 55
Study: 28750942

Group type: EXPERIMENTAL
Intervention: Hovenia dulcis Thunb. fruit extract (HDE) 2460mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hovenia dulcis Thunb. fruit extract (HDE)
Number of subjects: 26
Study: 26454835

Group type: EXPERIMENTAL
Intervention: memantine 30mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 80
Study: 24097301

Group type: EXPERIMENTAL
Intervention: CPV (AES Ultra CPV™)
Number of subjects: 170

Group type: COMPARATOR
Intervention: LMA (LMA Classic™)
Number of subjects: 170
Study: 21751854

Group type: EXPERIMENTAL
Intervention: Running on grass
Number of subjects: 20

Group type: COMPARATOR
Intervention: Running on asphalt
Number of subjects: 20
Study: 19333080

Group type: EXPERIMENTAL
Intervention: Purified chick embryo cell rabies vaccine administered intramuscularly or intradermally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Japanese encephalitis vaccine
Number of subjects: 0
Study: 16394700

Group type: EXPERIMENTAL
Intervention: Patient-controlled thoracic epidural analgesia
Number of subjects: 113

Group type: COMPARATOR
Intervention: General anesthesia followed by patient-controlled analgesia with intravenous morphine
Number of subjects: 113
Study: 15235161

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.1 mg/kg/dose intravenously, 3 doses)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control (standard neonatal intensive care)
Number of subjects: 115
Study: 11726250

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate loading (20 g per day for 7 days)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo loading
Number of subjects: 31
Study: 9233870

Group type: COMPARATOR
Intervention: Educational program taught by physical therapists, consisting of a two-session back school (three hours of training) followed by three to four reinforcement sessions over several years.
Number of subjects: 4000
Study: 7895385

Group type: EXPERIMENTAL
Intervention: Fibrin sealant haemostasis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diathermy haemostasis
Number of subjects: 50
Study: 2855221

Group type: EXPERIMENTAL
Intervention: Propranolol-adrenaline infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supramaximal dose of GRF 1-44 (200 micrograms, i.v.)
Number of subjects: 0
Study: 30860410

Group type: EXPERIMENTAL
Intervention: Hamstring foam rolling
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lacrosse ball on the plantar surface of the foot
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of both interventions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study: 29729589

Group type: EXPERIMENTAL
Intervention: Incongruent visual feedback (VF)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Congruent visual feedback (VF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No visual feedback (VF)
Number of subjects: 24
Study: 28512069

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES) with ultra-thin struts and biodegradable polymer
Number of subjects: 330

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (EES) with thin struts and durable polymer
Number of subjects: 330
Study: 26651542

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping above the perineum
Number of subjects: 101

Group type: COMPARATOR
Intervention: Delayed cord clamping below the perineum
Number of subjects: 101
Study: 24177278

Group type: EXPERIMENTAL
Intervention: Innovative dental implant design with tapered and cylindrical shape, placed under different protocols.
Number of subjects: 141
Study: 21164352

Group type: EXPERIMENTAL
Intervention: Olanzapine (16.2 mg for AA, 16.6 mg for CA)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 231
Study: 18321302

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC 55730
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17361520

Group type: EXPERIMENTAL
Intervention: Shehuang Paste (SHP) navel sticking, applied once a day for one month
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (basic treatment including liver protecting medicines, diuretics, and supportive drugs)
Number of subjects: 59
Study: 12968235

Group type: EXPERIMENTAL
Intervention: GIK therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 11044775

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg/day
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 8811135

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS) toothpaste
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cocoamidopropyl betaine (CAPB) toothpaste
Number of subjects: 30

Group type: COMPARATOR
Intervention: Detergent-free paste
Number of subjects: 30